TransCelerate BioPharma Inc.: TransCelerate BioPharma to Highlight Collaboration, Innovation, and Patient-Centric Research at DIA 2025
TransCelerate BioPharma (TransCelerate), a nonprofit organization dedicated to improving the health of people around the world by accelerating and simplifying the clinical research process, today announced its participation in numerous sessions at the DIA 2025 Global Annual Meeting in Washington, D.C. from June 15–19.